SMMT
NASDAQ
US
Summit Therapeutics Inc. - Common Stock
$19.38
▲ +$0.46
(+2.43%)
Vol 3.1M
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$13.0B
ROE
-52.2%
Margin
-9027.1%
D/E
0.00
Beta
-1.57
52W
$16–$37
Wall Street Consensus
23 analysts · Apr 20264
Strong Buy
13
Buy
5
Hold
1
Sell
0
Strong Sell
73.9%
Buy Rating
Price Chart
Similar Stocks
UTHR
United Therapeutics Corp
P/E 16.5
$21.0B
RVMD
Revolution Medicines Inc
$15.4B
MRNA
Moderna Inc
$11.5B
INCY
Incyte Corp
P/E 16.3
$19.4B
BBIO
BridgeBio Pharma Inc
$14.7B
NBIX
Neurocrine Biosciences Inc
P/E 33.0
$14.1B
MDGL
Madrigal Pharmaceuticals Inc
$13.2B
IONS
Ionis Pharmaceuticals Inc
$12.8B
EXEL
Exelixis Inc
P/E 17.3
$11.8B
Earnings
Beat rate: 25.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.07 | $-0.29 | $-0.22 |
| Sep 2025 | $-0.13 | $-0.31 | $-0.18 |
| Jun 2025 | $-0.10 | $-0.12 | $-0.02 |
| Mar 2025 | $-0.09 | $-0.09 | +$0.00 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -52.2% | -52.2% | -52.2% | -52.2% | -52.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -9027.1% | -9027.1% | -9027.1% | -9027.1% | -9027.1% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 5.13 | 5.13 | 5.13 | 3.80 | 3.80 | 3.80 |
Key Ratios
ROA (TTM)
-41.7%
P/S (TTM)
13562.81
P/B
33.9
EPS (TTM)
$-0.25
CF/Share
$-1.21
52W High
$36.91
52W Low
$15.55
$15.55
52-Week Range
$36.91
How does SMMT compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
SMMT valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
13562.8
▲
105447%
above
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
33.9
▲
1276%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
SMMT profitability vs Biotechnology peers
ROE
-52.2%
▲
22%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
-9027.1%
▼
3048%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-41.7%
▲
11%
above
peers
(-46.7%)
vs Peers
vs Industry
In line
SMMT financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
3.8
▼
15%
below
peers
(4.4)
vs Peers
vs Industry
In line
Beta
-1.6
▼
262%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
SMMT fundamentals radar
SMMT
Peer median
Industry
SMMT profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
SMMT vs peers: key metrics
Latest News
No related news yet